FDA Alert: Antiepileptic Drugs
Links shared publicly online about this topic.
- 2,065total visits
FDA Alert: Antiepileptic Drugs
View full resource at drugs.com
Most Recently Shared on May 6, 2009 at 12:38 am By:
FDA Alert - FDA Approves Updated Labeling for Antiepileptic Drugs - http://tinyurl.com/dg3cr8
SAFETY ALERT: Drug Interactions with Victrelis and Ritonavir-Boosted Protease Inhibitors - MPR
empr.com — “The FDA has notified healthcare professionals that drug interactions between the HCV protease inhibitor Victrelis and certain ritonavir-boosted HIV protease inhibitors can potentially reduce the effectiveness when they are used together.” View full resource at empr.com
Most Recently Shared on April 26, 2012 at 9:07 pm By:
#SAFETY ALERT: Drug Interactions with Victrelis and Ritonavir-Boosted Protease Inhibitors #HIV #hepatitis http://t.co/U2hWg9sq
Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication
fda.gov — “Risk of renal impairment, hypotension, and hyperkalemia with concomitant use of aliskiren with angiotensin receptor blockers (ARBs) or angiotensin converting enzyme inhibitors (ACEIs) in patients with diabetes.” View full resource at fda.gov
Most Recently Shared on April 20, 2012 at 4:08 pm By:
#Safety ALERT: #Aliskiren-containing Meds: #pharm #endo #med #APRN - New Warning & Contraindication: http://t.co/0AgfKNXf
FDA creating mobile app for use during public health crises - - ModernMedicine
modernmedicine.com — “Prompted by the 2009 H1N1 influenza outbreak, the U.S. Food and Drug Administration (FDA) plans to create a mobile app to help it gather information and send out alerts about adverse reactions to experimental medications prescribed during a public health crisis.” View full resource at modernmedicine.com
Most Recently Shared on March 19, 2012 at 11:44 am By:
Public Health Found. Health Organization
FDA creating mobile app for use during public health crises - - ModernMedicine http://t.co/7JeSVVey
FDA announces Prilosec and others can be dangerous! |
buschchiropractic.com — “The FDA has recently announced an alert about the safety of proton pump inhibitors (PPIs). The following is a list of common products warned” View full resource at buschchiropractic.com
Most Recently Shared on March 12, 2012 at 5:00 pm By:
Busch Chiropractic CAM, Chiropractor, and Doctor
Many stomach problems can be avoided or corrected naturally! Be aware these drugs and otc products can have... http://t.co/YztpiM9Y
Safety Alerts Cite Cholesterol Drugs’ Side Effects - NYTimes.com
nytimes.com — “Federal health officials are adding new alerts to statins about the rare risks of memory loss, increased blood sugar levels and muscle pain.” View full resource at nytimes.com
Most Recently Shared on March 1, 2012 at 7:59 pm By:
Sidney Wolfe, MD Internist, Physician, and Doctor
New FDA warnings about #statins more reason that healthy people w/ #cholesterol levels < 240 shouldn't be taking them http://t.co/DciGdi6t
FDA warns of cholesterol drugs' side effects - San Jose Mercury News
mercurynews.com — “Health experts say value of drugs outweigh side effects” View full resource at mercurynews.com
Most Recently Shared on March 1, 2012 at 5:08 pm By:
drgazsi CAM and Naturopathic Doctor
The Fed added new safety alerts for statins citing risks of memory loss, diabetes and muscle pain. Not to say... http://t.co/2MC9NzAX
Drug Recalls | Drug Alerts | Arthritis Today Magazine
arthritistoday.org — “Use this quick guide to understand types of recalls and other terms issued by drug and device manufacturers and the FDA. Arthritis Today magazine.” View full resource at arthritistoday.org
Most Recently Shared on March 1, 2012 at 12:50 am By:
Arthritis Today Mag Health Magazine
Use this quick guide to understand types of recalls and other terms: http://t.co/CG9vEUHn
Safety Alerts Cite Cholesterol Drugs’ Side Effects - NYTimes.com
nytimes.com — “Federal health officials are adding new alerts to statins about the rare risks of memory loss, increased blood sugar levels and muscle pain.” View full resource at nytimes.com
Most Recently Shared on February 29, 2012 at 2:50 pm By:
#FDA adds new safety alerts to cholesterol-lowering drugs, citing cognitive problems for the first time http://t.co/LEaaVddi #Statins
SAFETY ALERT: Drug Interactions Between Protease Inhibitors for Hepatitis C and HIV - MPR
empr.com — “The FDA has notified healthcare professionals that drug interactions between the hepatitis C virus (HCV) protease inhibitor Victrelis (boceprevir; Merck) and certain ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors can potentially reduce the effectiveness of these medicines when they are used together.” View full resource at empr.com
Most Recently Shared on February 9, 2012 at 8:20 pm By:
SAFETY ALERT: Drug Interactions Between Protease Inhibitors for #Hepatitis C and #HIV http://t.co/bC6NTI6q
Proton Pump Inhibitors (PPIs) - Drug Safety Communication: Clostridum Difficile-Associated Diarrhea (CDAD) Can be Associated With Stomach Acid Drugs
fda.gov — “Symptoms may include watery stool, abdominal pain, and fever. Patients may go on to develop more serious intestinal conditions.” View full resource at fda.gov
Most Recently Shared on February 8, 2012 at 3:40 pm By:
Scott Hensley Health Organization
If that diarrhea just doesn't get better, your heartburn drug may be the reason. FDA on PPIs and C. diff. http://t.co/WdJwZYrt
FDA Consumer Health Information - FDA's MedWatch Safety Alerts: December 2011 - Yahoo! News
news.yahoo.com — “From Yahoo! News: SILVER SPRING, Md., Jan. 25, 2012 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has recently issued alerts or other safety information about a number of products, including -- dietary supplements that could be contaminated with Salmonella -- a blood thinner that may lead to bleeding problems -- A drug for abnormal heart rhythm that carries a risk of stroke, heart failure and death when used by certain people -- ADHD drugs that showed no evidence of an increa” View full resource at news.yahoo.com
Most Recently Shared on January 25, 2012 at 9:52 pm By:
Tom Heston, MD Physician, Doctor, and Family Medicine Doctor
FDA Consumer Health Information - FDA's MedWatch Safety Alerts: December 2011 - YAHOO! http://t.co/a6c7rquf #health
Simplest, reinforced FDA warnings found effective
news-medical.net — “The impact of efforts by the U.S. Food and Drug Administration to notify the general public and health care providers about unanticipated risks from approved medications has been "varied and unpredictable," according to a systematic review of published studies about FDA warnings and alerts over the last 20 years.” View full resource at news-medical.net
Most Recently Shared on January 20, 2012 at 3:24 pm By:
Diabetes News: Simplest, reinforced FDA warnings found effective: The impact of efforts by the U.S. Food and Dru... http://t.co/0CRME33h
Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity
fda.gov — “New Boxed Warning and Contraindication highlighting these risks added to product labeling.” View full resource at fda.gov
Most Recently Shared on January 13, 2012 at 5:25 pm By:
Ramsey Baghdadi Health Communicator
two new cases of PML with Seattle Genetics' Adcetris: http://t.co/lb13qx7p
Medical News: FDA Warns of Opioid Drug Mix-Up - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The FDA has issued a warning that pills, tablets, or caplets of Percocet and eight other opioid products packaged by Novartis for Endo Pharmaceuticals may have been mixed up, with one drug being packa” View full resource at medpagetoday.com
Most Recently Shared on January 9, 2012 at 5:38 pm By:
Medical News: FDA Warns of Opioid Percocet Drug Mix-Up - http://t.co/Vjho52k2
Ikaria INOmax DS Drug Delivery System: Class I Recall - Erratic Nitric Oxide (NO) Readings
fda.gov — “Adverse consequences may include hypoxia, hypotension, bradycardia, cardiac arrest, organ damage, acute respiratory distress syndrome (ARDS), neurological deficits, or death.” View full resource at fda.gov
Most Recently Shared on January 4, 2012 at 9:57 pm By:
Sandeep Pulim Physician, Doctor, and Health Communicator
FDA: Ikaria INOmax DS Drug Delivery System: Class I Recall - Erratic Nitric Oxide (NO) Readings: http://t.co/T9jcJp3I #HCSM
Advertisement
